SAN FRANCISCO--(BUSINESS WIRE)--DIMERx, Inc., a mid-stage biopharmaceutical company, today announced that it will present data at PAINWeek 2023, the 17 th Annual National Conference on Pain for ...
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage biopharmaceutical company entering growth phase, today announced it has been awarded a UG3/UH3 cooperative agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback